Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients

Transplantation

Volumn 62, Issue 8, 1996, Pages 1068-1071

  D'Agostino, D ^a   Gimenez, M ^a   Yamaguchi, B ^b   Glancszpigel, R ^c   Vinuesa, F ^a   Gamba, M ^a   Ciardullo, M ^a   De Santibanes E ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b Sandoz Argentina SACI   (Argentina)

^c EDYABE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ARTICLE; CLINICAL ARTICLE; DRUG FORMULATION; EMULSION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG TOLERANCE; EMULSIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; MICROCHEMISTRY;

EID: 0029910551     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610270-00007     Document Type: Article

References (12)

1. Grevel J. Absorption of cyclosporin A after oral dosing. Transplant Proc 1986; 18 (suppl 5): 9.
2. Drewe J, Beglinger C, Kissel T. The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol 1992; 33: 39.
3. Reymond JP, Sucker H, Vonderscher J. In vivo model for cyclosporin intestinal absorption in lipid vehicles. Pharm Res 1988; 5: 677.
4. Wassef R, Cohen Z, Nordgren S, Langer B. Absorption of oral cyclosporin and bowel function. Kidney Int 1985; 27: 593.
5. McCaughan GW, Bookallilm Sheil A. Short and long term cyclosporin dosage in liver transplant. Transplant Proc 1994; 26: 2674.
6. Vonderscher J, Meinzer A. Rationale for the development of Sandimmun Neoral. Transplant Proc 1994; 26: 2925.
7. Levy G, Grant D. Potential for CsA-Neoral in organ transplantation. Transplant Proc 1994; 26: 2932.
8. Trull AK, Tan KKC, Uttridge J, Bauver T, Alexander G, Jamieson N. Cyclosporin absorption from microemulsion formulation in liver transplant recipient. Lancet 1993; 341: 433.
9. Altraif Y, Levy G, Grant D. Pharmacokinetic studies of Sandimmun Neoral vs. Sandimmun in liver transplant recipients. Hepatology 1993; 18: 747.
10. Mueller EA, Kovarik JM, Van Bree JB, Tetzloff W, Grevel J, Kutz K. Improved dose-linearity of cyclosporin pharmacokinetics from a microemulsion formulation. Pharm Res 1994; 11: 301.
11. Kehrer BH, Whitington PF, Black DD. The effect of Roux-en-Y biliary enterostomy on the absorption of cyclosporin: relevance to poor drug bioavailability in children after orthotopic liver transplantation. Transplant Proc 1988; 20; 523.
12. Whitington PF, Emond JC, Whitington SH, et al. Small bowel length and the dose of cyclosporin in children after liver transplantation. N Engl J Med 1990; 322: 733.